BIOCRUDE TECHNOLOGIES USA, INC. Financial Statements (2026 and earlier)
Company Profile
| Business Address |
1255 PHILLIPS SQUARE, SUITE 605 MONTREAL, QC H3B 3G5 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 4953 - Refuse Systems (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 6/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 4 | 439 | 1,778 | 109,971 | 305 | ||||
| Cash and cash equivalent | 4 | 439 | 1,778 | 109,971 | 305 | ||||
| Other undisclosed current assets | 5,200 | 4,347 | |||||||
| Total current assets: | 5,204 | 4,786 | 1,778 | 109,971 | 305 | ||||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 13,890 | 15,933 | 17,895 | 20,854 | 19,697 | 23,752 | |||
| Total noncurrent assets: | 13,890 | 15,933 | 17,895 | 20,854 | 19,697 | 23,752 | |||
| TOTAL ASSETS: | 19,094 | 15,933 | 22,681 | 22,632 | 129,668 | 24,057 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 58,199 | 48,486 | 22,151 | 16,424 | 21,400 | 28,238 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | ✕ | 29,814 | 25,688 | 20,937 | ||
| Accrued liabilities | 24,648 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | 58,199 | 48,486 | (2,497) | (13,390) | (4,288) | 7,301 | |||
| Debt | 130,637 | 133,969 | 126,002 | 138,394 | 152,169 | 155,503 | |||
| Due to related parties | ✕ | ✕ | ✕ | 41,664 | 104,727 | 200,436 | |||
| Other undisclosed current liabilities | 133,293 | 71,539 | 24,913 | ||||||
| Total current liabilities: | 322,129 | 253,994 | 173,066 | 196,482 | 278,296 | 384,177 | |||
| Noncurrent Liabilities | |||||||||
| Total liabilities: | 322,129 | 253,994 | 173,066 | 196,482 | 278,296 | 384,177 | |||
| Equity | |||||||||
| Equity, attributable to parent | (299,033) | (234,082) | (146,997) | (171,257) | (147,017) | (358,516) | |||
| Common stock | 50,855 | 50,801 | 50,762 | 50,711 | 50,622 | 50,484 | |||
| Additional paid in capital | 9,100,972 | 8,885,166 | 8,728,705 | 8,523,756 | 8,167,646 | 7,617,783 | |||
| Accumulated other comprehensive income | 28,627 | 28,682 | 28,672 | 28,678 | 28,654 | 28,671 | |||
| Accumulated deficit | (9,479,487) | (9,198,731) | (8,955,136) | (8,774,402) | (8,343,939) | (8,055,454) | |||
| Stockholders' equity note, subscriptions receivable | (50,000) | ||||||||
| Equity, attributable to noncontrolling interest | (4,002) | (3,979) | (3,388) | (2,593) | (1,611) | (1,604) | |||
| Total equity: | (303,035) | (238,061) | (150,385) | (173,850) | (148,628) | (360,120) | |||
| TOTAL LIABILITIES AND EQUITY: | 19,094 | 15,933 | 22,681 | 22,632 | 129,668 | 24,057 | |||
Income Statement (P&L) (USD)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Gross profit: | ||||||||
| Operating expenses | (277,134) | (240,437) | (177,655) | (427,330) | (283,735) | (274,261) | ||
| Other undisclosed operating income | ||||||||
| Operating loss: | (277,134) | (240,437) | (177,655) | (427,330) | (283,735) | (274,261) | ||
| Nonoperating income (expense) (gain, Foreign Currency Transaction, before Tax) | 5,031 | |||||||
| Interest and debt expense | (3,754) | (3,871) | (4,125) | (4,750) | (15,366) | |||
| Loss from continuing operations: | (277,134) | (244,191) | (181,526) | (426,424) | (288,485) | (289,627) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (426,424) | (288,485) | (289,627) | |
| Other undisclosed net loss | (3,622) | |||||||
| Net loss: | (280,756) | (244,191) | (181,526) | (426,424) | (288,485) | (289,627) | ||
| Net income (loss) attributable to noncontrolling interest | (23) | (596) | (792) | (992) | 527 | |||
| Other undisclosed net income (loss) attributable to parent | 23 | 596 | (4,039) | |||||
| Net loss available to common stockholders, diluted: | (280,756) | (244,191) | (182,318) | (431,455) | (288,485) | (289,100) | ||
Comprehensive Income (USD)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (280,756) | (244,191) | (181,526) | (426,424) | (288,485) | (289,627) | ||
| Net income (loss) attributable to redeemable noncontrolling interest | (23) | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other comprehensive loss | (280,834) | (244,176) | (181,535) | (431,421) | (288,509) | (289,570) | ||
| Other undisclosed comprehensive income | 288,492 | 290,137 | ||||||
| Comprehensive loss: | (561,590) | (488,367) | (363,061) | (857,845) | (288,502) | (289,060) | ||
| Comprehensive loss, net of tax, attributable to noncontrolling interest | (596) | (792) | (992) | (7) | (510) | |||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | ||||||||
| Comprehensive loss, net of tax, attributable to parent: | (561,590) | (488,963) | (363,853) | (858,837) | (288,509) | (289,570) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.